Ribostamicin
{{Drugbox-lat | Verifiedfields = | Watchedfields = | verifiedrevid = 376278091 | IUPAC_name = (1R,2R,3S,4R,6S)-4,6-diamino-3-hidroksi-2-(β-D-ribofuranoziloksi)cikloheksil 2,6-diamino-2,6-dideoksi-α-D-glukopiranozid | image = Ribostamycin.svg | width = | image2 = | width2 =
| tradename = | Drugs.com = Internacionalno ime leka | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =
| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
| CAS_number_Ref = 
| CAS_number =
| CAS_supplemental = 53797-35-6
| ATC_prefix = J01
| ATC_suffix = GB10
| PubChem = 5066
| IUPHAR_ligand =
| DrugBank_Ref =
| DrugBank =
| UNII_Ref =
| UNII = 2Q5JOU7T53
| ChEMBL_Ref =
| ChEMBL = 1256830
| C=17 | H=34 | N=4 | O=10
| molecular_weight = 454,47266 g/mol
| smiles =
| StdInChI_Ref =
| StdInChI =
| StdInChIKey_Ref =
| StdInChIKey =
| synonyms = (2R,3S,4R,5R,6R)-5-amino-2-(aminometil)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2[(2S,3R,4S,5R)-3,4-dihidroksi-5-(hidroksimetil)oksolan-2-il]oksi3-hidroksicikloheksil]oksi}oksan-3,4-diol
}}
Ribostamicin je aminoglikozidni antibiotik.
Reference
[уреди | уреди извор]Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Mandel GL, Bannett JE, Dolin R, ур. (2000). Principles and Practise of Infectious Diseases (5 изд.). Philadelphia, PA: Churchill Livingstone. doi:10.1016/S1473-3099(10)70089-X. ISBN 044307593X.
